Pancreatic Cancer Research

ResearcherUniversity of UtahActive in the last 2 years

Kajsa E. Affolter

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1703-0535; OpenAlex author ID A5001580260. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Correction: Differential Control of Growth and Identity by HNF4α Isoforms in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1541-7786.mcr-25-1225↗
  2. Differential Control of Growth and Identity by HNF4α Isoforms in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1541-7786.mcr-25-0175↗
  3. Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2024.01.013↗
  4. MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. Co-author DOI 10.1084/jem.20221524↗
  5. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations … Co-author DOI 10.1158/1078-0432.ccr-22-3724↗
  6. Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma. Co-author DOI 10.1200/cci.22.00160↗
  7. Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcino… Co-author DOI 10.1016/j.neo.2021.06.005↗
  8. The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer. Co-author DOI 10.1002/cam4.2851↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ignacio Garrido‐Laguna · 5 shared papers, 2020–2024 · strength 0.72
  2. Eric Lee Snyder · 2 shared papers, 2025–2026 · strength 0.52
  3. Pengshu Fang · 2 shared papers, 2025–2026 · strength 0.52
  4. Richard A. Moffitt · 2 shared papers, 2025–2026 · strength 0.52
  5. Walter Alexander Orellana · 2 shared papers, 2025–2026 · strength 0.52
  6. Sean J. Mulvihill · 3 shared papers, 2021–2024 · strength 0.43
  7. Courtney L. Scaife · 3 shared papers, 2021–2023 · strength 0.42
  8. Mark R. Silvis · 1 shared paper, 2023 · strength 0.18
  9. Martin McMahon · 1 shared paper, 2023 · strength 0.18
  10. Conan Kinsey · 1 shared paper, 2023 · strength 0.18
  11. Davendra P. S. Sohal · 1 shared paper, 2024 · strength 0.17
  12. Max Miller Wattenberg · 1 shared paper, 2024 · strength 0.17
  13. Muhammad Shaalan Beg · 1 shared paper, 2024 · strength 0.17
  14. Syed Arif Ahmad · 1 shared paper, 2024 · strength 0.17
  15. Andrew M. Lowy · 1 shared paper, 2024 · strength 0.17
  16. Andrea Wang‐Gillam · 1 shared paper, 2024 · strength 0.17
  17. Gregory Lawrence Beatty · 1 shared paper, 2024 · strength 0.17
  18. Philip A. Philip · 1 shared paper, 2024 · strength 0.17
  19. Elena Gabriela Chiorean · 1 shared paper, 2024 · strength 0.17
  20. Rachna T. Shroff · 1 shared paper, 2023 · strength 0.16
  21. Heloisa Prado Soares · 1 shared paper, 2023 · strength 0.16
  22. Chris Nevala-Plagemann · 1 shared paper, 2023 · strength 0.16
  23. Peter J. Hosein · 1 shared paper, 2023 · strength 0.16
  24. Emil Lou · 1 shared paper, 2023 · strength 0.16
  25. Wolfgang Michael Korn · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.